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Hypertrophic hearts contain areas of hypoperfusion which can be visualized by increased NADH surface fluorescence during in 
vitro perfusion without oxygen-carrying particles under constant pressure and pacing. By contrast, fluorescence remained low 
when non-hypertrophic hearts were used instead. When during perfusion of normal hearts the pH of the medium was lowered 
from 7.5 to 7.0, areas of high fluorescence appeared in a few minutes. The high fluorescent areas under conditions of cardiac 
hypertrophy or pH 7.0 perfusion could be reduced by addition of superoxide dismutase. It indicates that oxygen free radicals 
interfere with proper flow regulation in areas of low pH. Fluorescence in hypertrophic hearts also diminished during addition of 
albumin-bound oleate to the standard, glucose-containing, medium. This is in agreement with our earlier finding of fatty acid 
protection from acidosis-initiated loss of capillary flow (Biochim. Biophys. Acta, 1033 (1990) 214-218). In contrast o low 
concentrations of free fatty acids, high concentrations interfere with tissue oxygenation. This has been illustrated by the use of 1 
mM octanoate, which after a few min caused the appearance of high fluorescent areas. We conclude that decompensation f 
flow in hypoperfused areas of heart, as occurs in hypertrophy, may be stimulated by acidosis and oxygen free radicals. 
Introduction 
Previous work has shown that the Langendorff rat 
heart, when paced at a rate of 300 beats/min,  but 
perfused with neither erythrocytes nor with fluorocar- 
bon as oxygen carriers, is borderline aerobic, as con- 
cluded from the continuous release of lactate. 
Glyco(geno)lysis inhibited by increase of O 2 supply 
by fluorocarbon addition [1,2]. Lowering of the pH of 
the perfusion medium results in loss of high affinity 
binding of Ca 2 + to membranes [3-5]. This results in a 
brief period of positive inotropy, accompanied by an 
increase of flow rate, followed by progressive decline of 
inotropy and flow so that ischemia follows [1,6,7]. This 
phenomenon may be delayed by fatty acids [6,7], which 
are known to have vasodilatory properties (compare 
ref. 8). Development of cardiac ischemia may be stud- 
ied by NADH fluorescence [6,9-11]. It allows the de- 
tection of small areas in which the ischemia begins so 
that early intervention of imminent ischemia may be 
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studied. We have selected to study the effect of super- 
oxide dismutase (SOD) as we found earlier that cardiac 
function, lost by hypoperfusion of Langendorff hearts, 
improves by SOD addition by the removal of oxygen 
free radicals (OFR) from the interstitium [12]. In the 
present investigation we also studied hypoperfusion i  
normal hearts by lowering the perfusion pH, in order 
to induce interstitial acidosis which may be involved in 
the progression of cardiac hypertrophy. These hearts 
contain hypoperfused areas [13] in which local acidosis, 
due to enhanced glycolysis, may be present. As the 
heterogeneous distribution of (imminent) ischemia 
make data of overall metabolic changes difficult to 
interpret, we refrained from determining metabolic 
parameters in the present investigation. 
Materials and Methods 
Male Wistar rats weighing between 220 and 320 g 
were used. The hearts were removed, cooled in cold 
perfusion medium and rapidly arranged for perfusion 
at 37°C and a pressure of 8.3 kPa according to the 
Langendorff technique with a medium consisting of 
128 mM NaC1, 4.7 mM KC1, 1 mM MgCI z, 0.4 mM 
NaH2PO 4, 20.2 mM NaHCO3, 1.3 mM CaC12, and 11 
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mM glucose [8]. Other additions are described under 
Results. All hearts were paced at 5 Hz. NADH surface 
fluorescence was done after excitation of about l cm 2 
of the left ventricle of Langendorff rat hearts with light 
of 360 nm and the emitted light (460-490 nm) regis- 
tered as described [10]. Images were recorded with a 
S-VHS Panasonic video-recorder and computer-ana- 
lyzed [10]. Normal hearts had a total ventricle weight 
of 1.00 _+ 0.04 g (n = 10) and hypertrophic hearts (ob- 
tained after suprarenal abdominal aorta banding; 15) 
of 1.52 _+ 0.06 g (n = 10). The values are mean values 
_+ standard error of the mean (S.E.M.). Oleate-con- 
taining medium was used when indicated and prepared 
by sonicating oleic acid with an equivalent amount of 
NaOH. The warm soap was added to fatty acid-free 
bovine serum albumin (molar ratio fatty acid to albu- 
min 4: 1). The freshly prepared stock solution was 
added to the other components of the perfusion buffer 
and filtered through Millipore filter (0.45 ~zm) and 0.1 
mM L-carnitine (a gift from Sigma Tau, Pomezia, Italy) 
was added. Most chemicals were from E. Merck 
(Darmstadt, Germany); SOD was from Boehringer 
(Mannheim, Germany). 
Results 
'Reducing power' of various substrates in Langendorff 
hearts" 
During perfusion of the paced rat Langendorff heart 
with standard perfusion medium (pH 7.5), containing 
11 mM glucose as substrate, NADH fluorescence of a 
representative area of the left ventricle was measured, 
and the acute change by adding various substrates was 
registered. Fig. 1 shows that the increase of NADH 
fluorescence by additional substrates tested (1-2 raM) 
decreased in the order:pyruvate > oleate > octanoate 
> lactate > beta-hydroxybutyrate/acetoacetate. Aver-
age values of n = 3 are presented. This led us to select 
pyruvate, octanoate and oleate in the present studies, 
as we assumed that an optimal supply of reducing 
equivalents to cardiomyocytes could limit breakdown 
of ATP and generation of (hypo)xanthine, substrate for 
(endothelial) xanthine oxidase-dependent O2-genera- 
tion. That the addition of pyruvate increases NADH 
fluorescence confirms that the NADH fluorescence 
observed is of mitochondrial and not of cytosolic origin 
[9], as in the latter case it would have declined instead, 
due to stimulation of lactate dehydrogenase activity. 
Sufficient 0 2 supply disrupted by acidosis; effects of 
respiratory substrates and superoxyde dismutase (SOD) 
As mentioned earlier, changing the pH of the stand- 
ard perfusion medium from 7.5 to 7.0 rapidly results in 
a decrease of coronary flow and contractility of the 
heart (after an initial increase of both parameters 
(compare ref. 7)). This is accompanied by the appear- 
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Fig. 1. Comparison of the NADH fluorescence of normal Langen- 
dorff hearts perfused with the substrates indicated (in addition to 
glucose), with the NADH fluorescence when perfuscd with glucose 
as the sole substrate (n = 3:mean + S.D.). 
ance of areas of high fluorescence (Fig. 2A,B). Addi- 
tion of pyruvate was not able to prevent pH 7.0 in- 
duced ischemia (not shown; n = 4). When SOD had 
been present in the pH 7.5 medium, the change to the 
pH 7.0 medium still led to immediate and strong 
increase of NADH fluorescence in large parts of the 
heart, which persisted. However, it gradually decreased 
when the SOD supply was also contained in the pH 7.0 
medium (Fig. 3). When after 30 min SOD in pH 7.0 
medium, pH 7.0 perfusion without SOD was contin- 
ued, no fluorescence increase was observed after 15 
min, suggestive for continued SOD activity in the inter- 
stitium when SOD supply was discontinued (not 
shown). The flow, that had decreased from about 8 
ml /min  per g (after 20 min perfusion in pH 7.5 
medium) to 1.9_+ 0.7 ml /min  per g (n = 6) after 15 
min pH 7.0 perfusion without SOD, generally did not 
Fig. 2. Effect of pH 7.0 perfusion on the NADH fluorescence of a 
normal heart: (A) a heart during pH 7.5perfusiom no ischemia is 
present as witnessed by the low fluorescence of the displayed left 
ventricle surface and (B) the same heart 3 min after switching from 
pH 7.5 to pH 7.0 perfusion; the white areas represent high NADH 
fluorescent ischemic areas. 
Fig. 3. Effect of SOD addition to the medium on ischemic areas 
induced by pH 7.0 perfusion: (A) a heart after 5 min pH 7.0 
perfusion and (B) the same heart 15 min after pH 7.0 perfusion with 
10 mg/l SOD in the perfusate. 
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from 7.5 to 7.0, the flow rapidly deteriorated, which 
resulted in increase of NADH fluorescence (Fig. 5). 
Hypertrophic hearts and NADH fluorescence 
From the start of Langendorff perfusion (pH 7.5 
and glucose as the only substrate), hypertrophic hearts 
show areas of high NADH fluorescence, that gradually 
increase in size and intensity. Fig. 6 shows that hyper- 
trophy is not a homogeneous phenomenon, probably 
due to different sarcomere/capil lary ratios in different 
areas [13]. The increase of fluorescence can be stopped 
and acutely reversed by the addition of vasodilators, 
like nitroprusside or adenosine, or by improvement of 
tissue oxygenation by fluorocarbon [11]. Addition of 0.8 
mM oleate (containing 0.2 mM bovine serum albumin 
and 0.1 mM carnitine) resulted in a gradual decrease 
of the fluorescent areas (Fig. 7; two examples of four 
experiments with similar effect). SOD (final concentra- 
tion 10 rag/l)  added instead of o leate/albumin/carni -  
drop when SOD was present (flow: 8.6 _+ 2.5 ml /min 
per g; n = 4). The large variation may be due to the 
overall heterogeneity of the phenomena. We inter- 
preted the absence of SOD effect when it was only 
supplied during pH 7.5 perfusion by its inability to 
penetrate into the interstitium when interendothelial 
junctions are tight. During pH 7.0 perfusion, SOD 
entry into the interstitium must have occurred, perhaps 
due to increased permeability by pH lowering, as will 
be discussed. 
Octanoate addition and NADH fluorescence 
Our previous experience [7], that albumin-bound 
oleate can prevent the strong decrease of flow by 
changing the pH of the perfusion medium from 7.5 to 
7.0, led us to use another fatty acid, octanoate, in the 
present study. This fatty acid as well as acetate has 
been shown by others to protect the energy state of 
glucose-perfused working rat hearts after respiratory 
acidosis [6]. Under our conditions, changing of the 
standard perfusion medium of pH 7.5 (with glucose) to 
one containing in addition 1 mM octanoate caused an 
immediate overall increase of fluorescence (cf. Fig. 1). 
After a few rain, areas of high NADH fluorescence 
became visible, which gradually increased in size (Fig. 
4). This phenomenon appeared to be reversible by 
continued perfusion without octanoate, requiring at 
least 30 min. This experiment was repeated thrice with 
similar result. Therefore 1 mM final concentration of 
octanoate probably resulted in redistribution of flow, 
which we had never seen when using oleate or pyruvate 
at pH 7.5 instead. In the latter cases a moderate, but 
evenly distributed fluorescence increase was seen, 
which served to construct Fig. 1. When during oc- 
tanoate addition the pH of the medium was switched 
Fig. 4. Effect of octanoate addition to the medium on NADH 
fluorescence of a normal heart: (A)prior to octanoate addition, (B) 1 
min after octanoate addition; there is a overall increase of NADH 
fluorescence, (C) 10 rain after octanoate addition; large ischemic 
areas are present a d(D) 10 min after switching back to perfusion 
without octanoate. 
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Fig. 5. Effect of pH change upon a normal he rt pcrfused with 
octanoate containing medium: (A) a heart during pH 7.5 perfusion 
with octanoate; note th ischemic areas and (B) the same heart 1 min 
after switching to pH 7.0 perfusion; the ischemic area has rapidly 
increased insize. 
tine also gradually diminished NADH fluorescence. 
Whereas the disappearance of ischemia by nitroprus- 
side, adenosine or fluorocarbon was a matter of sec- 
onds, the effects of oleate/albumin/carnit ine or SOD 
was a matter of minutes. The effect of SOD required a 
lag phase of about 15 min. Fig. 8 shows two examples 
out of four with similar effect (in a fifth experiment no 
effect was observed after 30 rain SOD perfusion). 
When SOD addition was stopped after 30 min, fluores- 
cence remained low (n = 4) for at least 30 min, suggest- 
ing persistent SOD activity in the interstitium. 
Discussion 
The present work indicates that in the absence of 
oxygen-carrying particles, the O2-saturated perfusion 
medium only provides borderline aerobiosis in paced 
normal Langendorff hearts. This is reflected by a low 
production rate of lactate [1,2], while NADH fluores- 
cence is low. Fluorescence rapidly increases when the 
pH of the medium is lowered to 7.0 or less. indicative 
of decreased flow in affected areas, as may have been 
expected from previous investigations in which either 
respiratory acidosis was effected in working hearts 
[6,14] or metabolic acidosis in Langendorff hearts [1,7]. 
The heterogeneous pattern of fluorescence increase by 
acidosis, induced by changing the pH of the medium 
from 7.5 to 7.0 during Langendorff perfusion in thc 
present work (Fig. 2), could be due to differences in 
the regulation of flow in different areas of the heart. 
Also, in hypertrophic hearts perfused with standard 
medium (pH 7.5) thc appearance of heterogeneously 
distributed high fluorescent areas became visible [111. 
They rapidly disappear when the coronau flow is in- 
creased by the addition of nitroprussidc OF adenosine 
[11]. Apparently, in those areas flow decreases progres- 
sively in the absence of added vasodilators o that a 
critical 0 2 level is quickly reached in which NADH of 
the mitochondrial respiratory chain accumulates. This 
is in agreement with the disappearance of NADH 
fluorescence by increasing the O 2 supply by addition of 
fluorocarbon to the perfusion medium [11]. This also 
limits lactic acid formation during pH 7.{) perfusion [1]. 
These observations suggest that local acidosis is a com- 
mon factor involved in the decline of flow in certain 
areas of pH 7.0-perfused control hearts or pH 7.5 
perfused hypertrophic hearts. Steenbergen ct al. [14] 
observed that "acidosis-induced ischemia is charac- 
terized by relatively large areas of high fluorescence as 
opposed to the mottled appearance of high flow hy- 
poxia". They concluded from this that changes of coro- 
nary circulation are important for the development of 
the anoxic zones [14]. Interestingly, mild acidosis may 
result in vasodilation, but severe acidosis constricts 
Fig. 6. Three examples of hypertrophic Langendorff hearts. Thewhite areas on the left ventricle surface are ischemic areas which developed 
within 5 min after the start of perfusion. 
vessels. As for acidosis and vasodilation, we observed 
that initially, after changing pH 7.5 to pH 7.0 perfu- 
sion, the contractility of non-working Langendorff 
hearts increased together with coronary flow [7]. Only 
after contractility had started to fall, did the increased 
flow gradually diminish and finally resulted in low flow 
ischemia, probably due to further decline of the pH in 
the tissue by lactic acid formation and ATP breakdown 
(1,7). Fatty acids also have dual effects on flow, de- 
pending on their free concentration. Low levels of 
long-chain fatty acids, bound to albumin, are vasodila- 
tors [8]. The initial effect of 1 mM octanoate on overall 
flow during pH 7.5 perfusion was also an increase 
(45 +_ 8%, n = 4, present study; compare also ref. 8)). 
However, after 5 min the overall flow had started to 
fall, while ischemic areas were formed (Fig. 4). When 
the octanoate-containing medium of pH 7.5 was 
changed into one of pH 7.0, the ischemic area largely 
increased within 5 min (Fig. 5), while the overall flow 
dropped to low values (1-3 ml/min per g). It suggests 
that the degree of fatty acid dissociation plays a role in 
their effectiveness to penetrate membranes. It has been 
iiiiiiiii!i il!iii iiill 
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Fig. 7. Effect of oleate addition to the perfusion medium on ischemic 
areas of hypertrophic hearts: (A) and (B) are images of 2 different 
hearts prior to oleate addition; (C) and (D) display the same hearts 
as (A) and (B) respectively, 2 min after switching to perfusion 
containing oleate. 
Fig. 8. Effect of SOD addition to the perfusion medium on ischemic 
areas of hypertrophic hearts: (A) and (B) are images of 2 different 
hearts prior to SOD addition; (C) and (D) display the same hearts as 
(A) and (B) respectively, 15 min after perfusion with SOD (10 mg/I) 
containing medium. 
shown that the effect of amphiphiles depends on the 
charge of these membrane-active agents [16]. Fatty 
acids and lysophospholipids have (indirect) ionophoric 
properties (compare refs. 8 and 16-18) which can 
affect the Ca 2÷ level in cells. In smooth muscle- and 
endothelial cells of blood vessels, amphiphiles affect 
the contractile state of these cells and influence capil- 
lary flow. They may also cause edema, as had been 
seen earlier by employing 5 mM octanoate during pH 
7.5 Langendorff perfusion. After an initial flow in- 
crease, the flow rate progressively decreased, which 
was accompanied by the release of lactate, adenosine, 
inosine and hypoxanthine, suggestive of insufficient 
oxygenation [8]. In those experiments macroscopic 
edema appeared, judged by the shiny appearance of 
the heart and increase of its size. In the present 
experiments in which 1 mM octanoate was used in- 
stead, macroscopic edema did not occur during 30 min 
perfusion. Yet, extravasation of fluid may have been 
present as restoration of low fluorescence by oc- 
tanoate-free perfusion only slowly occurred during a 
30-min further observation. 
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The interstit ial  space plays an important  role in the 
init iation of cardiac hypertrophy [19]. Increase of the 
permeabi l i ty  of endothel ium by fatty acids and/or  aci- 
dosis has been descr ibed by many authors. A relation 
between protons and fatty acids on permeabi l i ty  of 
capi l lar ies may be the natural  presence of fatty acids in 
membranes,  which at pH 7.4 are mainly in ionized 
form and as such part of the bi layer structure. How- 
ever, upon acidif ication, unionized species may escape 
from lamel lar  structures [20,21] and activate membrane 
processes, that result in increased intracel lu lar  Ca e ÷ 
levels. The increased penetrat ion of vascular con- 
st ituents into the interstit ial  space may also be the 
reason why SOD was able to enter  the interst it ium 
during pH 7.0 perfusion and not during the previous 
pH 7.5 perfusion in the exper iments hown in Fig. 3. 
These i l lustrate improvement  of flow during acidosis by 
SOD. The benif icial  effect of SOD on tissue oxygena- 
tion also appl ies to pH 7.5 perfused hypertrophic  earts 
(Fig. 8). It indicates also that in hypertrophic hearts 
extracel lular OFR interferes with the regulat ion of 
capi l lary flow. This could be due to the ability of OFR 
to destroy endothel ium-der ived relaxing factor [22]. A 
low rate of secret ion and/or  adequate  removal of OFR 
from the outside of endothel ia l  cells is most important  
to prevent ischemia. This may also be the basis of the 
inhibitory effect of a lbumin-complexed oleate upon the 
progression of flow decrease during pH 7.0 perfusion 
of normal hearts [7] and to pH 7.5-perfused hyper- 
trophic hearts, in which hypoperfusion may even disap- 
pear  under the condit ions of the tests (Fig. 7). The 
explanat ion may be that during fatty acid oxidation in 
the (peri)vascular area, in which 0 2 is still present,  
lactic acid formation is inhibited and endothe l ium-de-  
rived relaxing factor is increased [23]. 
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